ArticleJID innovations : skin science from molecules to population health2026
Clinician and Patient Perspectives in Oral Lichen Planus: Correlation and Drivers of Disease Severity and QOL.
Article in JID innovations : skin science from molecules to population health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral lichen planus is a chronic, immune-mediated inflammatory condition that significantly impacts QOL. Clinician-reported measures, such as the Oral Disease Severity Score (ODSS), systematically evaluate clinical severity but may not adequately reflect patient experience. Patient-reported outcome measures, such as the Chronic Oral Mucosal Disease Questionnaire (COMDQ-26), provide QOL insights, although their relationship with clinical severity remains underexplored. This study aimed to assess alignment between clinician-assessed severity (measured by ODSS) and patient-reported QOL (measured by COMDQ-26) in oral lichen planus across sex and disease subtypes as well as to identify key drivers of these scores. A retrospective review of 78 patients with oral lichen planus was conducted with assessment of demographics, disease subtypes, ODSS, COMDQ-26, and pain scores. Erythematous and erosive/ulcerative subtypes had the highest severity and QOL impact scores, with no significant score differences between these subtypes. ODSS components (site, activity, pain) contributed equally to total severity, whereas the COMDQ-26 patient support domain most strongly drove QOL scores. Moderate ODSS-COMDQ-26 correlations indicated only partial alignment between clinician- and patient-reported measures. We conclude that integrating patient-reported outcome measures into clinical practice and trials may improve oral lichen planus care through more comprehensive, individualized, and subtype-focused strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.